Disc Medicine, Inc.

IRON Healthcare Biotechnology

EPS
+2.53%
Free cash flow
+7.83%
Total debt
+106.5%

Quarter to June 2026, against a year earlier

77.77 0.70 −0.89%
Market cap
$3.5B
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

Disc Medicine, Inc. (IRON) Current ratio

Alert me on Current ratio

Disc Medicine, Inc.'s current ratio at the end of the quarter to 30 June 2026 was 24.1×, up 2.2× from fiscal 2025 (21.9×). Over the past ten years it has ranged from 0.2× (fiscal 2020) to 21.9× (fiscal 2025) — the current reading is the highest in ten years. That is above the Biotechnology industry median of 4.9× and above the Healthcare sector median of 3.1×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 21.9× 3.63%
FY2024 21.2× 24.13%
FY2023 17.1× 94.01%
FY2022 8.8× 0.00%
FY2022 8.8× 30.43%
FY2021 6.7× 0.00%
FY2021 6.7× 3,210.66%
FY2020 0.2× 0.00%
FY2020 0.2× —

Quarterly newest first

Period Current ratio Change
Jun 2026 24.1× 0.56%
Mar 2026 24.0× 9.40%
Dec 2025 21.9× (6.44%)
Sep 2025 23.5× (26.96%)
21 more quarters

Against its own ten years

Low 0.2× High 21.9×
Ten-year median 8.8×
Current reading's percentile 100

Current ratio against peers

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on IRON